PD-L1 is commonly overexpressed on tumor cells in multiple cancers, including head and neck squamous cell carcinoma (HNSCC) and OSCC, where it interacts with PD-1 on T-cells to suppress their cytotoxic activity [13,14]. The gene discussed is CD274; the disease is neoplasm.